UiPath stock joins healthcare AI program after Q2 growth

Published on 10/04/2026 at 15:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UiPath stock closed at USD 13.12 on October 2 after a 1.50 percent decline. Q2 revenue rose 13 percent to USD 410.26 million and ARR reached USD 1.938 billion.

PATH, US90364P1057, Illustration mit AI erstellt.

UiPath stock (ISIN US90364P1057) closed at USD 13.12 on the NYSE on October 2, 2026, down 1.50 percent from the prior close. The company joined the NCQA AI Learning Collaborative for responsible healthcare AI on October 1, 2026, giving its automation platform a concrete entry point into prior authorization workflows, as UiPath reported.

Healthcare AI adds a new use case

The collaborative brings healthcare organizations together to evaluate and scale AI with governance, peer learning and measurable outcomes. UiPath will contribute practical implementation experience as the initial work centers on prior authorization, an area shaped by operational and regulatory demands, according to UiPath on October 1, 2026.

The move follows a broader platform strategy. On September 30, 2026, UiPath announced a two-way integration with Snowflake that lets customers bring governed Snowflake data into UiPath automations and trigger workflows from Snowflake, as the company said in its newsroom.

Q2 revenue and ARR move higher

UiPath reported fiscal second-quarter revenue of USD 410.26 million for the period ended July 31, 2026, up 13 percent year over year, while ARR reached USD 1.938 billion, up 12 percent, according to The Globe and Mail in its transcript dated September 3, 2026.

The quarter also produced USD 32 million in GAAP operating income, the fourth consecutive quarter of GAAP profitability. Non-GAAP operating income reached USD 89 million, equal to a 22 percent margin, while 18 of the company's 20 largest deals included AI components, the transcript reported.

Management guided fiscal 2027 revenue to USD 1.789 billion to USD 1.794 billion and ARR to USD 2.065 billion to USD 2.070 billion. The third-quarter revenue outlook is USD 440 million to USD 445 million, providing a measurable test of whether the AI-led platform strategy can keep converting into growth.

Analyst targets stay above the stock

Zacks lists a Moderate Hold brokerage consensus based on 20 recommendations and an average price target of USD 15.60 from 15 analyst reports. The targets span USD 10.00 to USD 23.00, and the average stands 18.90 percent above the October 2 closing price of USD 13.12.

The market is therefore weighing two different signals: operating profitability and rising AI engagement on one side, and the need to sustain growth on the other. That tension is visible in the stock's October 2 decline despite the latest quarter's double-digit revenue and ARR gains.

UiPath stock closes below its yearly midpoint

UiPath stock closed at USD 13.12 on the NYSE on October 2, 2026. The USD 9.20 to USD 19.84 52-week range places the shares USD 6.72 below the yearly high, while market capitalization stood at USD 7.0 billion.